Published in EMBO J on December 01, 2003
Structure and function of enzymes in heme biosynthesis. Protein Sci (2010) 1.48
One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans. Biochim Biophys Acta (2012) 1.46
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci U S A (2007) 1.35
Chelatases: distort to select? Trends Biochem Sci (2006) 1.18
Substrate interactions with human ferrochelatase. Proc Natl Acad Sci U S A (2007) 1.14
Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS One (2012) 1.08
Erythroid heme biosynthesis and its disorders. Cold Spring Harb Perspect Med (2013) 0.95
Uroporphyrinogen decarboxylation as a benchmark for the catalytic proficiency of enzymes. Proc Natl Acad Sci U S A (2008) 0.95
Reduction of porphyrins to porphyrinogens with palladium on carbon. Anal Biochem (2008) 0.90
Structure and mechanistic implications of a uroporphyrinogen III synthase-product complex. Biochemistry (2008) 0.85
Siroheme: an essential component for life on earth. Plant Signal Behav (2010) 0.84
Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogen. J Mol Biol (2009) 0.83
HemQ: An iron-coproporphyrin oxidative decarboxylase for protoheme synthesis in Firmicutes and Actinobacteria. Arch Biochem Biophys (2015) 0.83
Crystal structure of uroporphyrinogen decarboxylase from Bacillus subtilis. J Bacteriol (2006) 0.81
Functional definition of the tobacco protoporphyrinogen IX oxidase substrate-binding site. Biochem J (2007) 0.81
Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase. Protein Sci (2007) 0.78
The structure, function and properties of sirohaem decarboxylase--an enzyme with structural homology to a transcription factor family that is part of the alternative haem biosynthesis pathway. Mol Microbiol (2014) 0.78
Prokaryotic Heme Biosynthesis: Multiple Pathways to a Common Essential Product. Microbiol Mol Biol Rev (2017) 0.77
Iron Response Regulator Protein IrrB in Magnetospirillum gryphiswaldense MSR-1 Helps Control the Iron/Oxygen Balance, Oxidative Stress Tolerance, and Magnetosome Formation. Appl Environ Microbiol (2015) 0.76
Molecular evolution of multiple-level control of heme biosynthesis pathway in animal kingdom. PLoS One (2014) 0.75
A porphodimethene chemical inhibitor of uroporphyrinogen decarboxylase. PLoS One (2014) 0.75
Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases. Cell Mol Biol (Noisy-le-grand) (2009) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27
Raster3D: photorealistic molecular graphics. Methods Enzymol (1997) 27.30
An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest (1976) 2.83
Macrocyclic intermediates in the biosynthesis of porphyrins. Philos Trans R Soc Lond B Biol Sci (1976) 2.73
Electrostatic stress in catalysis: structure and mechanism of the enzyme orotidine monophosphate decarboxylase. Proc Natl Acad Sci U S A (2000) 2.18
The crystal structure and mechanism of orotidine 5'-monophosphate decarboxylase. Proc Natl Acad Sci U S A (2000) 1.90
The mechanism of orotidine 5'-monophosphate decarboxylase: catalysis by destabilization of the substrate. Biochemistry (2000) 1.57
X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. Biochemistry (1999) 1.39
Crystal structure of human uroporphyrinogen decarboxylase. EMBO J (1998) 1.26
Crystal structure of human uroporphyrinogen III synthase. EMBO J (2001) 1.23
Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase. Biochemistry (1983) 1.20
A mouse model of familial porphyria cutanea tarda. Proc Natl Acad Sci U S A (2001) 1.11
Stereochemical and mechanistic studies on the decarboxylation of uroporphyrinogen III in haem biosynthesis. J Chem Soc Perkin 1 (1979) 1.07
Characterization and crystallization of human uroporphyrinogen decarboxylase. Protein Sci (1997) 1.02
Circe effect versus enzyme preorganization: what can be learned from the structure of the most proficient enzyme? Chembiochem (2001) 1.01
Crystal structure and substrate binding modeling of the uroporphyrinogen-III decarboxylase from Nicotiana tabacum. Implications for the catalytic mechanism. J Biol Chem (2001) 0.96
Evidence for participation of aspartate-84 as a catalytic group at the active site of porphobilinogen deaminase obtained by site-directed mutagenesis of the hemC gene from Escherichia coli. Biochemistry (1994) 0.94
Pyruvoyl-dependent histidine decarboxylase. Active site structure and mechanistic analysis. J Biol Chem (1989) 0.94
The modification of acetate and propionate side chains during the biosynthesis of haem and chlorophylls: mechanistic and stereochemical studies. Ciba Found Symp (1994) 0.93
Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. J Invest Dermatol (1989) 0.91
Ubiquitin-binding domains. Nat Rev Mol Cell Biol (2005) 6.77
X-ray structures of the hexameric building block of the HIV capsid. Cell (2009) 4.08
Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome. Nat Genet (2006) 3.94
Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell (2007) 3.06
Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med (2005) 2.95
Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science (2005) 2.94
Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol (2005) 2.73
The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. Mol Cell (2005) 2.68
Structural and mechanistic studies of VPS4 proteins. EMBO J (2005) 2.58
UNC119 is required for G protein trafficking in sensory neurons. Nat Neurosci (2011) 2.38
Retracted The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab (2008) 2.25
Biosynthesis of heme in mammals. Biochim Biophys Acta (2006) 2.25
Structure and ubiquitin binding of the ubiquitin-interacting motif. J Biol Chem (2003) 2.19
Ubiquitin recognition by the human TSG101 protein. Mol Cell (2004) 2.17
Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion (2002) 2.15
Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes. Am J Hum Genet (2003) 2.11
Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J Virol (2006) 2.06
Structural basis for ESCRT-III protein autoinhibition. Nat Struct Mol Biol (2009) 1.98
ALIX-CHMP4 interactions in the human ESCRT pathway. Proc Natl Acad Sci U S A (2008) 1.91
Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation. Mol Cell (2007) 1.85
Crystal structure of the middle and C-terminal domains of the flagellar rotor protein FliG. EMBO J (2002) 1.79
The structure of the yFACT Pob3-M domain, its interaction with the DNA replication factor RPA, and a potential role in nucleosome deposition. Mol Cell (2006) 1.78
Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol (2007) 1.78
Structural insights into the catalytic mechanism of cyclophilin A. Nat Struct Biol (2003) 1.78
Potent D-peptide inhibitors of HIV-1 entry. Proc Natl Acad Sci U S A (2007) 1.76
Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat Struct Mol Biol (2007) 1.76
Crystal structure of the flagellar rotor protein FliN from Thermotoga maritima. J Bacteriol (2005) 1.65
Clinical consequences of iron overload in hemochromatosis homozygotes. Blood (2003) 1.65
Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest (2010) 1.64
Proteasome activators. Mol Cell (2011) 1.62
A method for detecting recent selection in the human genome from allele age estimates. Genetics (2003) 1.55
The pore of activated 20S proteasomes has an ordered 7-fold symmetric conformation. EMBO J (2003) 1.50
Structural biology of the proteasome. Annu Rev Biophys (2013) 1.42
Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278). Biochemistry (2006) 1.41
Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology (2004) 1.41
Structural basis for ubiquitin recognition by the human ESCRT-II EAP45 GLUE domain. Nat Struct Mol Biol (2006) 1.41
Structural and functional analysis of the Spt16p N-terminal domain reveals overlapping roles of yFACT subunits. J Biol Chem (2007) 1.38
Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterology (2006) 1.38
An asymmetric interface between the regulatory and core particles of the proteasome. Nat Struct Mol Biol (2011) 1.36
Structure of a Blm10 complex reveals common mechanisms for proteasome binding and gate opening. Mol Cell (2010) 1.36
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. Proc Natl Acad Sci U S A (2007) 1.35
A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress. Genes Dev (2009) 1.33
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance. J Virol (2010) 1.33
Cryo-EM structure of dodecameric Vps4p and its 2:1 complex with Vta1p. J Mol Biol (2008) 1.33
A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. Am J Hum Genet (2006) 1.31
Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc Natl Acad Sci U S A (2010) 1.29
Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet (2003) 1.26
Structure of the Blm10-20 S proteasome complex by cryo-electron microscopy. Insights into the mechanism of activation of mature yeast proteasomes. J Mol Biol (2006) 1.22
Structural models for interactions between the 20S proteasome and its PAN/19S activators. J Biol Chem (2009) 1.17
Crystal structure of a biliverdin IXalpha reductase enzyme-cofactor complex. J Mol Biol (2002) 1.17
Structures along the catalytic pathway of PrmC/HemK, an N5-glutamine AdoMet-dependent methyltransferase. Biochemistry (2003) 1.17
Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets. Protein Sci (2014) 1.16
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Blood (2006) 1.16
Crystal structure and RNA binding of the Tex protein from Pseudomonas aeruginosa. J Mol Biol (2008) 1.15
Biochemical and structural studies of yeast Vps4 oligomerization. J Mol Biol (2008) 1.15
Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood (2007) 1.13
Molecular architecture of a dynamin adaptor: implications for assembly of mitochondrial fission complexes. J Cell Biol (2010) 1.10
The structure of Saccharomyces cerevisiae Met8p, a bifunctional dehydrogenase and ferrochelatase. EMBO J (2002) 1.09
Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1. J Virol (2010) 1.06
Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis. J Biol Chem (2007) 1.06
Regulation of iron absorption in Hfe mutant mice. Blood (2002) 1.05
Structure of ATP-bound human ATP:cobalamin adenosyltransferase. Biochemistry (2006) 1.04
Structural and biochemical characterization of Gun4 suggests a mechanism for its role in chlorophyll biosynthesis. Biochemistry (2005) 1.04
Proteasome degradation: enter the substrate. Trends Cell Biol (2003) 1.02
Structural basis of ubiquitylation. Curr Opin Struct Biol (2002) 1.02
Hereditary hemochromatosis. Semin Hematol (2002) 1.01
How to assemble a capsid. Cell (2007) 1.00
X-ray structures of isopentenyl phosphate kinase. ACS Chem Biol (2010) 1.00
Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology. Circulation (2002) 1.00
Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma. Genes Cancer (2010) 0.98
Structure of the Spt16 middle domain reveals functional features of the histone chaperone FACT. J Biol Chem (2013) 0.98
Activation of the retroviral budding factor ALIX. J Virol (2011) 0.97
Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi. Blood (2009) 0.96
Crystal structure of the oxygen-dependant coproporphyrinogen oxidase (Hem13p) of Saccharomyces cerevisiae. J Biol Chem (2004) 0.96
Structure of an actin-related subcomplex of the SWI/SNF chromatin remodeler. Proc Natl Acad Sci U S A (2013) 0.93
Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change. J Biol Chem (2007) 0.92
Crystal structures of the S. cerevisiae Spt6 core and C-terminal tandem SH2 domain. J Mol Biol (2011) 0.91
Reduction of porphyrins to porphyrinogens with palladium on carbon. Anal Biochem (2008) 0.90
Structure and biological importance of the Spn1-Spt6 interaction, and its regulatory role in nucleosome binding. Mol Cell (2010) 0.89
Identification of a novel mutation (C321X) in HJV. Blood (2004) 0.88
Structure of a proteasome Pba1-Pba2 complex: implications for proteasome assembly, activation, and biological function. J Biol Chem (2012) 0.87
Down-regulation of hepcidin in porphyria cutanea tarda. Blood (2008) 0.86
Investigation of treatment failure in neonatal echovirus 7 infection. Pediatr Infect Dis J (2006) 0.86